We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission.
- Authors
Borghi, A.; Mantovani, L.; Minghetti, S.; Giari, S.; Virgili, A.; Bettoli, V.
- Abstract
Background Aimed at the reduction of post-treatment relapse of severe acne, the cumulative dose of oral isotretinoin should be ≥120 mg/kg. However, data on the appropriate oral isotretinoin treatment regimen in mild and moderate acne are lacking. Objective The purpose of this study was to determine the efficacy of an isotretinoin-sparing protocol in inducing permanent remission of mild and moderate acne. Methods In this open, prospective, non-comparative study, 150 patients affected with mild-to-moderate acne were treated with isotretinoin until complete recovery and for a further month of treatment, independent of the total cumulative dose reached. Patients then underwent a 1-year maintenance therapy with adapalene 0.1% cream. Patients were followed up for a further year, without any treatment. Results A total of 139 patients completed the study. Overall, patients received a mean of 80.92 mg/kg cumulative dose of isotretinoin. In the 2-year follow-up, relapse only appeared in 13 patients (9.35%). Conclusion Comparing our findings with published data, this isotretinoin-sparing regimen was shown to be effective in inducing stable remission and preventing acne relapses in patients with mild-to-moderate acne. Low-cumulative dose regimens may potentially lead to a lower incidence of side-effects and to lower costs than higher doses.
- Subjects
ACNE; SKIN disease treatment; ISOTRETINOIN; DRUG dosage; DRUG side effects; DISEASE relapse; THERAPEUTICS
- Publication
Journal of the European Academy of Dermatology & Venereology, 2011, Vol 25, Issue 9, p1094
- ISSN
0926-9959
- Publication type
Article
- DOI
10.1111/j.1468-3083.2010.03933.x